Gerri Henwood
Overview
Gerri Henwood received an average of $2M in total compensation, including $324K in salary, at Baudax Bio from 2019 to 2021. Gerri Henwood also received an average of $2M at Recro Pharma from 2013 to 2020.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Baudax BioPresident and Chief Executive Officer
Baudax BioPresident and Chief Executive Officer
Recro PharmaFormer President and Chief Executive Officer
Baudax BioPresident and Chief Executive Officer
Recro PharmaPresident and Chief Executive Officer
Recro PharmaPresident and Chief Executive Officer
Recro PharmaPresident and Chief Executive Officer
Recro PharmaPresident and Chief Executive Officer
Recro PharmaPresident and Chief Executive Officer
Recro PharmaPresident and Chief Executive Officer
Source: SEC filings on March 31, 2022, March 11, 2021, March 25, 2021, March 27, 2020, March 20, 2019, March 23, 2018, March 28, 2017, April 12, 2016, and April 29, 2015.
Related executives
We found nine more executives who work or worked at Baudax Bio and Recro Pharma.
J Enloe
Recro Pharma
Chief Executive Officer
Ryan Lake
Recro Pharma
Chief Financial Officer
Richard Casten
Baudax Bio
Chief Financial Officer
Michael Celano
Recro Pharma
Chief Operating Officer
Ryan Lake
Recro Pharma
Chief Financial Officer
Stewart McCallum
Recro Pharma
Chief Medical Officer
Fred Graff
Recro Pharma
Chief Commercial Officer
Randall Mack
Recro Pharma
Senior Vice President, Development
News
Baudax Bio CEO Gerri Henwood's 2021 pay jumps 178% to $1.7M
March 31, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020
Recro Pharma CEO Gerri Henwood's 2018 pay rises 16% to $2.4M
March 20, 2019